Coronary heart disease and the management of risk: Patient perspectives of outcomes associated with the clinical implementation of the National Service Framework targets

Health, Risk and Society

Volumn 9, Issue 4, 2007, Pages 359-373

  Crinson, Iain ^a   Shaw, Adrienne ^a   Durrant, Ruth ^b   De Lusignan, Simon ^a   Williams, Brian ^b  

^a Hunter Wing   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cardiac risk; Medical dependency; National Service Framework; Regulation

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTRACT; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK MANAGEMENT; SELF CARE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 35349031715     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698570701612527     Document Type: Article

References (31)

1. Anggard, E. E., Land, J. M., Lenihan, C. J., Packard, C. J., Percy, M. J. and Ritchie, L. D. (1986) Prevention of cardiovascular disease in general practice: A proposed model. British Medical Journal, 293:6540, pp. 177-180.
2. ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events), Bowker, T. J., Clayton, T. C., Ingham, J., McLennan, N. R., Hobson, H. L. and Pyke, S. D. (1996) A British Cardiac Society survey of the potential for the secondary prevention of coronary disease. Heart, 75:4, pp. 334-342.
3. Barbour, R. S. and Kitzinger, J. (1998) Developing Focus Group Research: Politics, Theory and Practice, Sage, London
4. Beck, U. (1992) Risk Society: Towards a New Modernity, Sage, London
5. Benson, J. and Britten, N. (2002) Patients decisions about whether or not to take anti-hypertensive drugs: Qualitative study. BMJ, 325, p. 873.
6. Berg, J., Dischler, J., Wagner, D., Raia, J. and Palmer-Shevlin, N. (1993) Medication compliance: A healthcare problem. Annals of Pharmacotherapy, 27:9, pp. 1-14.
7. Dean, M. (1999) Governmentality, Power and Rule in Modern Society, Sage, London
8. Department of Health (2000) National Service Framework for Coronary Heart Disease, DoH, London
9. Department of Health (2004) GMS Statement of Financial Entitlements (SFE) 2004/5, DH, London
10. Department of Health (2004) The NHS Improvement Plan: Putting People at the Heart of Public Services Cm 6268, The Stationary Office, London
11. Department of Health (2005) The Coronary Heart Disease National Service Framework: Leading the Way - Progress Report 2005, DH Publications, London
12. Dowell, J. and Hudson, H. (1997) A qualitative study of medication-taking behaviour in primary care. Family Practice, 14, pp. 369-375.
13. Evans, J., McNaughton, D., Donnan, P. and MacDonald, T. (2001) Pharmacoepidemiological research at the Medicines Monitoring Unit, Scotland: Data protection and confidentiality. Pharmacoepidemiology and Drug Safety, 10:7, pp. 669-673.
14. Foucault, M. (1977) Discipline and Punish: The Birth of the Prison, Allen Lane, London
15. Jaeger, C., Renn, O., Rosa, E. and Webler, T. (2001) Risk, Uncertainty, and Rational Action, James & James/Earthscan, London
16. Leitch, D. (1989) Who should have their cholesterol concentration measured? What experts in the United Kingdom suggest. British Medical Journal, 298:6688, pp. 1615-1616.
17. Levick, J. (2003) An Introduction to Cardiovascular Physiology, Arnold, London
18. Lewis, D., Robinson, J. and Wilkinson, E. (2003) Factors involved in deciding to start preventative treatment: Qualitative study of clinicians and lay people's attitudes. BMJ, 327, pp. 841-847.
19. Lupton, D. (1995) The Imperative of Health: Public Health and the Regulated Body, Sage, London
20. OXCHECK Study Group (1991) Prevalence of risk factors for heart disease in OXCHECK trial: Implications for screening in primary care. British Medical Journal, 302:6784, pp. 1057-1060.
21. Redfern, J., MacKevitt, C. and Wolfe, C. (2006) Risk management after stroke: The limits of a patient-centred approach. Health, Risk & Society, 8:2, pp. 123-141.
22. Ritchie, J. and Spencer, L. (1994) Qualitative data analysis for applied policy research. Analysing Qualitative Data, Routledge, London
23. Ritchie, J., Spencer, L. and O'Connor, W. (2003) Carrying out qualitative analysis. Qualitative Research Practice, Sage, London
24. Royal Pharmaceutical Society (1997) From compliance to concordance: Achieving shared goals in medicine taking, RPS, London
25. Scandinavian Simvastatin Survival Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet, 344:8934, pp. 1383-1389.
26. Shaper, A., Pocock, S. and Walker, M. (1985) Risk factors for ischaemic heart disease: The prospective phase of the British regional heart study. Journal of Epidemiology Community Health, 39, pp. 197-209.
27. Stamler, J., Wentworth, D. and Neaton, J. D. (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 256, pp. 2823-2828.
28. Taylor-Gooby, P. (2006) Trust, risk and health care reform. Health, Risk & Society, 8:2, pp. 97-103.
29. Turner, B. (1987) Medical Power and Social Knowledge, Sage, London
30. Williams, B., Poulter, N., Brown, M., Davis, M., McInnes, G. and Potter, J. (2004) British Hypertension Society Guidelines. Guidelines for the management of hypertension: Report of the fourth working party of the British Hypertension Society BHS IV. Journal of Human Hypertension, 18, pp. 139-185.
31. Williams, B., Shaw, A., Durrant, R., Crinson, I., Pagliari, C. and de Lusignan, S. (2005) Patient perspectives on multiple medication taking and attitudes towards combining pills: A qualitative study of acceptability and adherence in the context of hypertension and hypercholesterolaemia. Quarterly Journal of Medicine, 98, pp. 885-893.